- Home
- ARVN vs MQY Comparison
ARVN vs MQY Comparison
Compare ARVN & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARVN | MQY |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 836.1M |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ARVN | MQY |
|---|---|---|
| Price | $10.47 | $11.18 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $15.35 | N/A |
| AVG Volume (30 Days) | ★ 763.2K | 373.7K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $10.52 |
| 52 Week High | $14.22 | $11.94 |
Technical Indicators
Market Signals| Indicator | ARVN | MQY |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 23.64 |
| Support Level | $9.02 | $11.17 |
| Resistance Level | $14.03 | $11.25 |
| Average True Range (ATR) | 0.69 | 0.08 |
| MACD | -0.32 | -0.05 |
| Stochastic Oscillator | 2.36 | 6.72 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.